Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$555K Buy
1,533
+559
+57% +$191K 0.33% 81
2026
Q1
$343K Sell
974
-2,036
-68% -$726K 0.25% 91
2025
Q4
$985K Sell
3,010
-235
-7% -$74.5K 0.24% 89
2025
Q3
$916K Sell
3,245
-2,206
-40% -$640K 0.25% 90
2025
Q2
$1.52M Buy
5,451
+2,698
+98% +$764K 0.45% 51
2025
Q1
$858K Sell
2,753
-1,128
-29% -$333K 0.28% 81
2024
Q4
$1.01M Buy
3,881
+1,063
+38% +$315K 0.33% 68
2024
Q3
$908K Sell
2,818
-36
-1% -$11.8K 0.29% 78
2024
Q2
$892K Sell
2,854
-1,080
-27% -$317K 0.31% 71
2024
Q1
$1.12M Buy
3,934
+1,811
+85% +$530K 0.44% 51
2023
Q4
$611K Sell
2,123
-130
-6% -$35.4K 0.26% 81
2023
Q3
$605K Sell
2,253
-2,965
-57% -$740K 0.29% 75
2023
Q2
$1.16M Sell
5,218
-598
-10% -$139K 0.56% 42
2023
Q1
$1.41M Buy
5,816
+2,597
+81% +$637K 0.74% 32
2022
Q4
$845K Sell
3,219
-144
-4% -$38.6K 0.49% 48
2022
Q3
$758K Sell
3,363
-45
-1% -$10.9K 0.43% 58
2022
Q2
$829K Sell
3,408
-629
-16% -$154K 0.45% 55
2022
Q1
$976K Sell
4,037
-2,049
-34% -$471K 0.41% 64
2021
Q4
$1.37M Buy
6,086
+1,488
+32% +$314K 0.55% 49
2021
Q3
$978K Buy
4,598
+1,330
+41% +$306K 0.43% 62
2021
Q2
$797K Buy
+3,268
New +$804K 0.36% 70

Other funds holding AMGN

KG&L Capital Management's AMGN Position: Q2 2026 in Review

KG&L Capital Management increased its Amgen (AMGN) stake by 57% in Q2 2026, buying an estimated $191K and bringing the position to 1,533 shares worth $555K. The position accounts for 0.33% of the portfolio, ranked #81.

KG&L Capital Management first reported a position in AMGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.52M in Q2 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • KG&L Capital Management held 1,533 shares of Amgen worth $555K as of Q2 2026.
  • KG&L Capital Management bought 559 Amgen shares in Q2 2026, an estimated $191K.
  • Amgen made up 0.33% of KG&L Capital Management's portfolio in Q2 2026, its #81 holding.
  • KG&L Capital Management first reported a position in Amgen in Q2 2021 and has held it in 21 quarters since.
  • KG&L Capital Management's Amgen position peaked at $1.52M in Q2 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on KG&L Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.